
/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;
DROP TABLE IF EXISTS `proteins`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `proteins` (
  `id` int(10) NOT NULL AUTO_INCREMENT,
  `nome` text NOT NULL,
  `cod_id` varchar(10) NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=396 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

LOCK TABLES `proteins` WRITE;
/*!40000 ALTER TABLE `proteins` DISABLE KEYS */;
INSERT INTO `proteins` VALUES (1,'CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN','1BM0'),(2,'CRYSTAL STRUCTURE OF BACTERIORHODOPSIN IN THE LIGHT-ADAPTED STATE','1BM1'),(3,'GRB2-SH2 DOMAIN IN COMPLEX WITH CYCLO-[N-ALPHA-ACETYL-L-THI','1BM2'),(4,'IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX','1BM3'),(5,'MOMLV CAPSID PROTEIN MAJOR HOMOLOGY REGION PEPTIDE ANALOG','1BM4'),(6,'THE SOLUTION STRUCTURE OF A SITE-DIRECTED MUTANT (R111M) OF HUMAN','1BM5'),(7,'SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1','1BM6'),(8,'HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC','1BM7'),(9,'DNA-BINDING DOMAIN OF MBP1','1BM8'),(10,'REPLICATION TERMINATOR PROTEIN FROM BACILLUS SUBTILIS','1BM9'),(11,'BENZYL METHYL AMINIMIDE INHIBITOR COMPLEXED TO PORCINE PANCREATIC','1BMA'),(12,'GRB2-SH2 DOMAIN IN COMPLEX WITH KPFY*VNVEF (PKF270-974)','1BMB'),(13,'STRUCTURE OF A ZINC METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS','1BMC'),(14,'DETERMINANTS OF PROTEIN THERMOSTABILITY OBSERVED IN THE 1.9 ANGSTROMS','1BMD'),(15,'BOVINE MITOCHONDRIAL F1-ATPASE','1BMF'),(16,'CRYSTAL STRUCTURE OF BOVINE BETA2-MICROGLOBULIN','1BMG'),(17,'THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655','1BMK'),(18,'COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE','1BML'),(19,'HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-4-[(AMINOIMINOMETHYL)','1BMM'),(20,'HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-1-(AMINOIMINOMETHYL)-','1BMN'),(21,'BM-40, FS/EC DOMAIN PAIR','1BMO'),(22,'BONE MORPHOGENETIC PROTEIN-7','1BMP'),(23,'CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA','1BMQ'),(24,'ALPHA-LIKE TOXIN LQH III FROM SCORPION LEIURUS QUINQUESTRIATUS','1BMR'),(25,'CRYSTAL STRUCTURE OF MS2 CAPSIDS WITH MUTATIONS IN THE SUBUNIT FG LOOP','1BMS'),(26,'HOW A PROTEIN BINDS B12: A 3.O ANGSTROM X-RAY STRUCTURE OF THE B12-','1BMT'),(27,'PROTEIN-RNA INTERACTIONS IN AN ICOSAHEDRAL VIRUS AT 3.0','1BMV'),(28,'A FIBRONECTIN TYPE III FOLD IN PLANT ALLERGENS: THE SOLUTION STRUCTURE','1BMW'),(29,'HIV-1 CAPSID PROTEIN MAJOR HOMOLOGY REGION PEPTIDE ANALOG, NMR, 8','1BMX'),(30,'HUMAN TRANSTHYRETIN (PREALBUMIN)','1BMZ'),(31,'STRUCTURE OF PENTAERYTHRITOL TETRANITRATE REDUCTASE IN','1H60'),(32,'STRUCTURE OF PENTAERYTHRITOL TETRANITRATE REDUCTASE IN','1H61'),(33,'STRUCTURE OF PENTAERYTHRITOL TETRANITRATE REDUCTASE IN COMPLEX WITH 1,','1H62'),(34,'STRUCTURE OF THE REDUCED PENTAERYTHRITOL TETRANITRATE','1H63'),(35,'CRYSTAL STRUCTURE OF THE SM-RELATED PROTEIN OF P. ABYSSI','1H64'),(36,'CRYSTAL STRUCTURE OF PEA TOC34 - A NOVEL GTPASE OF THE CHLOROPLAST','1H65'),(37,'CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH','1H66'),(38,'NMR STRUCTURE OF THE CH DOMAIN OF CALPONIN','1H67'),(39,'SENSORY RHODOPSIN II','1H68'),(40,'CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE','1H69'),(41,'REDUCED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE','1H6A'),(42,'REDUCED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE','1H6B'),(43,'OXIDIZED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE','1H6C'),(44,'OXIDIZED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE','1H6D'),(45,'MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED','1H6E'),(46,'HUMAN TBX3, A TRANSCRIPTION FACTOR RESPONSIBLE FOR ULNAR-MAMMARY','1H6F'),(47,'ALPHA-CATENIN M-DOMAIN','1H6G'),(48,'STRUCTURE OF THE PX DOMAIN FROM P40PHOX BOUND TO PHOSPHATIDYLINOSITOL','1H6H'),(49,'A REFINED STRUCTURE OF HUMAN AQUAPORIN 1','1H6I'),(50,'THE THREE-DIMENSIONAL STRUCTURE OF CAPSULE-SPECIFIC','1H6J'),(51,'NUCLEAR CAP BINDING COMPLEX','1H6K'),(52,'BETA-PROPELLER PHYTASE IN COMPLEX WITH PHOSPHATE AND','1H6L'),(53,'COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF HEN EGG WHITE LYSOZYME','1H6M'),(54,'FORMATION OF A TYROSYL RADICAL INTERMEDIATE IN PROTEUS MIRABILIS','1H6N'),(55,'DIMERISATION DOMAIN FROM HUMAN TRF1','1H6O'),(56,'DIMERISTION DOMAIN FROM HUMAN TRF2','1H6P'),(57,'TRANSLATIONALLY CONTROLLED TUMOR-ASSOCIATED PROTEIN P23FYP FROM','1H6Q'),(58,'THE OXIDIZED STATE OF A REDOX SENSITIVE VARIANT OF GREEN FLUORESCENT','1H6R'),(59,'ASYMMETRIC CONDUCTIVITY OF ENGINEERED PROTEINS','1H6S'),(60,'INTERNALIN B: CRYSTAL STRUCTURE OF FUSED N-TERMINAL DOMAINS.','1H6T'),(61,'INTERNALIN H: CRYSTAL STRUCTURE OF FUSED N-TERMINAL DOMAINS.','1H6U'),(62,'MAMMALIAN THIOREDOXIN REDUCTASE','1H6V'),(63,'CRYSTAL STRUCTURE OF A HEAT- AND PROTEASE-STABLE FRAGMENT OF THE','1H6W'),(64,'THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE','1H6X'),(65,'THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE','1H6Y'),(66,'RIBOSOMAL ELONGATION FACTOR G (EF-G) FUSIDIC ACID RESISTANT MUTANT','2BM0'),(67,'RIBOSOMAL ELONGATION FACTOR G (EF-G) FUSIDIC ACID RESISTANT','2BM1'),(68,'HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)-','2BM2'),(69,'STRUCTURE OF THE TYPE II COHESIN FROM CLOSTRIDIUM','2BM3'),(70,'THE STRUCTURE OF MFPA (RV3361C, C2 CRYSTAL FORM). THE','2BM4'),(71,'THE STRUCTURE OF MFPA (RV3361C, P21 CRYSTAL FORM). THE','2BM5'),(72,'THE STRUCTURE OF MFPA (RV3361C, C2221 CRYSTAL FORM). THE','2BM6'),(73,'THE STRUCTURE OF MFPA (RV3361C, P3221 CRYSTAL FORM). THE','2BM7'),(74,'CMCI-N160 APO-STRUCTURE','2BM8'),(75,'CMCI-N160 IN COMPLEX WITH SAM','2BM9'),(76,'THE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM GLUTAMATE','2BMA'),(77,'X-RAY STRUCTURE OF THE BIFUNCTIONAL 6-HYDROXYMETHYL-7,8-','2BMB'),(78,'AURORA-2 T287D T288D COMPLEXED WITH PHA-680632','2BMC'),(79,'HIGH RESOLUTION STRUCTURE OF GDP-BOUND HUMAN RAB4A','2BMD'),(80,'HIGH RESOLUTION STRUCTURE OF GPPNHP-BOUND HUMAN RAB4A','2BME'),(81,'DENGUE VIRUS RNA HELICASE AT 2.4A','2BMF'),(82,'CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50','2BMG'),(83,'MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN','2BMH'),(84,'METALLO-BETA-LACTAMASE','2BMI'),(85,'GTPASE LIKE DOMAIN OF CENTAURIN GAMMA 1 (HUMAN)','2BMJ'),(86,'FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH','2BMK'),(87,'OFLOXACIN-LIKE ANTIBIOTICS INHIBIT PNEUMOCOCCAL CELL WALL','2BML'),(88,'X-RAY STRUCTURE OF A NOVEL THERMOSTABLE HEMOGLOBIN FROM THE','2BMM'),(89,'THE CRYSTAL STRUCTURE OF NITROBENZENE DIOXYGENASE','2BMO'),(90,'THE CRYSTAL STRUCTURE OF NITROBENZENE DIOXYGENASE IN COMPLEX WITH','2BMQ'),(91,'THE CRYSTAL STRUCTURE OF NITROBENZENE DIOXYGENASE IN COMPLEX WITH 3-','2BMR'),(92,'SCORPION TOXIN BMTX2 FROM BUTHUS MARTENSII KARSCH, NMR, 25 STRUCTURES','2BMT'),(93,'UMP KINASE FROM PYROCOCCUS FURIOSUS COMPLEXED WITH ITS','2BMU'),(94,'APOFLAVODOXIN FROM HELICOBACTER PYLORI','2BMV'),(95,'FERREDOXIN: NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY, ALA','2BMW'),(96,'MYCOBACTERIUM TUBERCULOSIS AHPC','2BMX'),(97,'BANANA LECTIN','2BMY'),(98,'BANANA LECTIN BOUND TO XYL-B1,3 MAN-A-O-METHYL (XM)','2BMZ'),(99,'SOLUTION STRUCTURE OF HUMAN BRG1 BROMODOMAIN','2H60'),(100,'X-RAY STRUCTURE OF HUMAN CA2+-LOADED S100B','2H61'),(101,'CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF','2H62'),(102,'CRYSTAL STRUCTURE OF HUMAN BILIVERDIN REDUCTASE A','2H63'),(103,'CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2','2H64'),(104,'CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO','2H65'),(105,'THE CRYSTAL STRUCTURE OF PLASMODIUM VIVAX 2-CYS','2H66'),(106,'NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B5-ALA, HIS-B10-ASP PRO-B28-','2H67'),(107,'HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1','2H68'),(108,'CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM','2H6A'),(109,'CRYSTAL STRUCTURE OF OXIDIZED CPRK IN COMPLEX WITH O-','2H6B'),(110,'CRYSTAL STRUCTURE OF REDUCED CPRK IN ABSENCE OF ANY LIGAND','2H6C'),(111,'PROTEIN KINASE DOMAIN OF THE HUMAN 5\'-AMP-ACTIVATED PROTEIN KINASE','2H6D'),(112,'CRYSTAL STRUCTURE OF THE D-ARABINOSE DEHYDROGENASE FROM SULFOLOBUS','2H6E'),(113,'PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYLATED DDPTASACVLS','2H6F'),(114,'W102T PROTEIN FARNESYLTRANSFERASE MUTANT COMPLEXED WITH A','2H6G'),(115,'Y365F PROTEIN FARNESYLTRANSFERASE MUTANT COMPLEXED WITH A FARNESYLATED','2H6H'),(116,'W102T/Y365F PROTEIN FARNESYLTRANSFERASE DOUBLE MUTANT COMPLEXED WITH A','2H6I'),(117,'CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME','2H6J'),(118,'HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1','2H6K'),(119,'X-RAY CRYSTAL STRUCTURE OF THE METAL-CONTAINING PROTEIN','2H6L'),(120,'AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF','2H6M'),(121,'HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1','2H6N'),(122,'EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN','2H6O'),(123,'CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450','2H6P'),(124,'HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1','2H6Q'),(125,'CRYSTAL STRUCTURE OF TRIOSEPHOSPHATE ISOMERASE (TIM) FROM','2H6R'),(126,'SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS','2H6S'),(127,'SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS COMPLEXED','2H6T'),(128,'CRYSTAL STRUCTURE OF 5-HYDROXYISOURATE HYDROLASE (FORMERLY KNOWN AS','2H6U'),(129,'SPECTROSCOPIC AND STRUCTURAL STUDY OF THE HETEROTROPIC LINKAGE BETWEEN','2H6V'),(130,'CRYSTAL STRUCTURE OF THIOREDOXIN WILD TYPE IN HEXAGONAL (P61) SPACE','2H6X'),(131,'CRYSTAL STRUCTURE OF THIOREDOXIN MUTANT E48D IN HEXAGONAL (P61) SPACE','2H6Y'),(132,'CRYSTAL STRUCTURE OF THIOREDOXIN MUTANT E44D IN HEXAGONAL (P61) SPACE','2H6Z'),(133,'STRUCTURE OF DNA OCTAMER G(DUSE)G(5-SEDU)ACAC','3BM0'),(134,'CRYSTAL STRUCTURE OF A MINIMAL NITROREDUCTASE YDJA FROM ESCHERICHIA','3BM1'),(135,'CRYSTAL STRUCTURE OF A MINIMAL NITROREDUCTASE YDJA FROM ESCHERICHIA','3BM2'),(136,'RESTRICTION ENDONUCLEASE PSPGI-SUBSTRATE DNA COMPLEX','3BM3'),(137,'CRYSTAL STRUCTURE OF HUMAN ADP-RIBOSE PYROPHOSPHATASE NUDT5 IN COMPLEX','3BM4'),(138,'CRYSTAL STRUCTURE OF O-ACETYL-SERINE SULFHYDRYLASE FROM ENTAMOEBA','3BM5'),(139,'AMPC BETA-LACTAMASE IN COMPLEX WITH A P.CARBOXYPHENYLBORONIC ACID','3BM6'),(140,'CRYSTAL STRUCTURE OF A PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE','3BM7'),(141,'CRYSTAL STRUCTURE OF YOPH MUTANT D356A COMPLEXED WITH IRREVERSIBLE','3BM8'),(142,'DISCOVERY OF BENZISOXAZOLES AS POTENT INHIBITORS OF','3BM9'),(143,'CRYSTAL STRUCTURE OF D-ALANYL-LIPOTEICHOIC ACID SYNTHETASE FROM','3BMA'),(144,'CRYSTAL STRUCTURE OF A NEW RNA POLYMERASE INTERACTING','3BMB'),(145,'STRUCTURE OF PTERIDINE REDUCTASE 1 (PTR1) FROM TRYPANOSOMA BRUCEI IN','3BMC'),(146,'STRUCTURE OF PTERIDINE REDUCTASE 1 (PTR1) FROM TRYPANOSOMA BRUCEI IN','3BMN'),(147,'STRUCTURE OF PTERIDINE REDUCTASE 1 (PTR1) FROM TRYPANOSOMA BRUCEI IN','3BMO'),(148,'HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2)','3BMP'),(149,'STRUCTURE OF PTERIDINE REDUCTASE 1 (PTR1) FROM TRYPANOSOMA BRUCEI IN','3BMQ'),(150,'CYCLODEXTRIN GLYCOSYL TRANSFERASE FROM THERMOANEROBACTERIUM','3BMV'),(151,'CYCLODEXTRIN GLYCOSYL TRANSFERASE FROM THERMOANEROBACTERIUM','3BMW'),(152,'BETA-N-HEXOSAMINIDASE (YBBD) FROM BACILLUS SUBTILIS','3BMX'),(153,'DISCOVERY OF BENZISOXAZOLES AS POTENT INHIBITORS OF CHAPERONE HSP90','3BMY'),(154,'VIOLACEIN BIOSYNTHETIC ENZYME VIOE','3BMZ'),(155,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H60'),(156,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H61'),(157,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H62'),(158,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H63'),(159,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H64'),(160,'THE CRYSTAL STRUCTURE OF C176A MUTATED [FE]-HYDROGENASE (HMD)','3H65'),(161,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H66'),(162,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H67'),(163,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H68'),(164,'CATALYTIC DOMAIN OF HUMAN SERINE/THREONINE PHOSPHATASE 5','3H69'),(165,'STRUCTURE OF THE CALX-BETA DOMAIN OF INTEGRIN BETA4','3H6A'),(166,'CRYSTAL STRUCTURE OF HUMAN ALPHA-DEFENSIN 1 (MUTANT GLN22ALA)','3H6C'),(167,'STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS DUTPASE D28N MUTANT','3H6D'),(168,'THE CRYSTAL STRUCTURE OF A CARBOHYDRATE KINASE FROM NOVOSPHINGOBIUM','3H6E'),(169,'CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME','3H6F'),(170,'CRYSTAL STRUCTURE OF THE GLUR6 AMINO TERMINAL DOMAIN DIMER ASSEMBLY','3H6G'),(171,'CRYSTAL STRUCTURE OF THE GLUR6 AMINO TERMINAL DOMAIN DIMER ASSEMBLY','3H6H'),(172,'CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME','3H6I'),(173,'CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE FROM PSEUDOMONAS','3H6J'),(174,'CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID-DEHYDROGENASE BOUND','3H6K'),(175,'CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V104E','3H6M'),(176,'CRYSTAL STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN OF PLEXIN D1','3H6N'),(177,'ACTIVATOR-BOUND STRUCTURE OF HUMAN PYRUVATE KINASE M2','3H6O'),(178,'CRYSTAL STRUCTURE OF RV3019C-RV3020C FROM MYCOBACTERIUM TUBERCULOSIS','3H6P'),(179,'MACROCYPIN, A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR','3H6Q'),(180,'CLITOCYPIN, A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR','3H6R'),(181,'STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX','3H6S'),(182,'CRYSTAL STRUCTURE OF THE IGLUR2 LIGAND-BINDING CORE (S1S2J-N754S) IN','3H6T'),(183,'CRYSTAL STRUCTURE OF THE IGLUR2 LIGAND-BINDING CORE (S1S2J-N754S) IN','3H6U'),(184,'CRYSTAL STRUCTURE OF THE IGLUR2 LIGAND-BINDING CORE (S1S2J-N754S) IN','3H6V'),(185,'CRYSTAL STRUCTURE OF THE IGLUR2 LIGAND-BINDING CORE (S1S2J-N754S) IN','3H6W'),(186,'CRYSTAL STRUCTURE OF DUTPASE FROM STREPTOCOCCUS MUTANS','3H6X'),(187,'CRYSTAL STRUCTURE OF THE FOUR MBT REPEATS OF DROSOPHILA MELANOGASTER','3H6Z'),(188,'CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM','4BM0'),(189,'CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS','4BM1'),(190,'CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS','4BM2'),(191,'CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS','4BM3'),(192,'CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS','4BM4'),(193,'CHLOROPLAST INNER MEMBRANE PROTEIN TIC110','4BM5'),(194,'CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION','4BM7'),(195,'GALECTIN-3C IN COMPLEX WITH BISAMIDO-THIOGALACTOSIDE DERIVATE 3','4BM8'),(196,'STRUCTURE OF THE AUTOINHIBITED PARKIN CATALYTIC DOMAIN','4BM9'),(197,'STRUCTURAL OF ASPERGILLUS FUMIGATUS UDP-N-ACETYLGLUCOSAMINE','4BMA'),(198,'CRYSTAL STRUCTURE OF THE N TERMINAL DOMAIN OF HUMAN GALECTIN 8','4BMB'),(199,'CRYSTAL STRUCTURE OF S.POMBE RAD4 BRCT1,2','4BMC'),(200,'CRYSTAL STRUCTURE OF S.POMBE RAD4 BRCT3,4','4BMD'),(201,'CRYSTAL STRUCTURE OF THE N TERMINAL DOMAIN OF HUMAN GALECTIN 8, F19Y','4BME'),(202,'SOLUTION STRUCTURE OF THE CELLULOSE-BINDING DOMAIN OF','4BMF'),(203,'CRYSTAL STRUCTURE OF HEXAMERIC HBC149 Y132A','4BMG'),(204,'CRYSTAL STRUCTURE OF SSHAT','4BMH'),(205,'STRUCTURE OF THE UBZ1AND2 TANDEM OF THE UBIQUITIN-BINDING ADAPTOR','4BMJ'),(206,'SERINE PALMITOYLTRANSFERASE K265A FROM S. PAUCIMOBILIS WITH','4BMK'),(207,'C-ALPHA BACKBONE TRACE OF MAJOR CAPSID PROTEIN GP39 FOUND IN MARINE','4BML'),(208,'CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR','4BMM'),(209,'APO STRUCTURE OF SHORT-CHAIN ALCOHOL DEHYDROGENASE FROM','4BMN'),(210,'CRYSTAL STRUCTURE OF BACILLUS CEREUS RIBONUCLEOTIDE REDUCTASE','4BMO'),(211,'CRYSTAL STRUCTURE OF BACILLUS CEREUS  RIBONUCLEOTIDE','4BMP'),(212,'CRYSTAL STRUCTURE OF RIBONUCLEOTIDE REDUCTASE APO-NRDF FROM','4BMQ'),(213,'CRYSTAL STRUCTURE OF RIBONUCLEOTIDE REDUCTASE APO-NRDF FROM','4BMR'),(214,'SHORT CHAIN ALCOHOL DEHYDROGENASE FROM RALSTONIA SP. DSM','4BMS'),(215,'CRYSTAL STRUCTURE OF RIBONUCLEOTIDE REDUCTASE DI-IRON NRDF','4BMT'),(216,'CRYSTAL STRUCTURE OF RIBONUCLEOTIDE REDUCTASE DI-MANGANESE(II)','4BMU'),(217,'SHORT-CHAIN DEHYDROGENASE FROM SPHINGOBIUM YANOIKUYAE IN','4BMV'),(218,'CRYSTAL STRUCTURE OF THE STREPTOMYCES RETICULI HBPS E78D, E81D DOUBLE','4BMW'),(219,'NATIVE STRUCTURE OF FUTALOSINE HYDROLASE OF HELICOBACTER','4BMX'),(220,'STRUCTURE OF FUTALOSINE HYDROLASE MUTANT OF HELICOBACTER','4BMY'),(221,'STRUCTURE OF FUTALOSINE HYDROLASE MUTANT OF HELICOBACTER PYLORI','4BMZ'),(222,'HIGH RESOLUTION STRUCTURE OF VIBRIO CHOLERAE CHEMOTAXIS PROTEIN CHEY4','4H60'),(223,'STRUCTURE OF THE SCHIZOSACCHAROMYCES POMBE MEDIATOR SUBUNIT MED6','4H61'),(224,'STRUCTURE OF THE SACCHAROMYCES CEREVISIAE MEDIATOR SUBCOMPLEX','4H62'),(225,'STRUCTURE OF THE SCHIZOSACCHAROMYCES POMBE MEDIATOR HEAD MODULE','4H63'),(226,'CRYSTAL STRUCTURE OF SEMET DERIVATIVE OF HMP SYNTHASE THI5 FROM S.','4H65'),(227,'CRYSTAL STRUCTURE OF HMP SYNTHASE THI5 FROM S. CEREVISIAE','4H67'),(228,'CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA','4H69'),(229,'CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA','4H6A'),(230,'STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS','4H6B'),(231,'CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA','4H6C'),(232,'CRYSTAL STRUCTURE OF PLP-SOAKED HMP SYNTHASE THI5 FROM S. CEREVISIAE','4H6D'),(233,'TRNA-GUANINE TRANSGLYCOSYLASE Y106F, C158V, V233G MUTANT APO STRUCTURE','4H6E'),(234,'CRYSTAL STRUCTURE OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR SCIN-B(4-85)','4H6H'),(235,'CRYSTAL STRUCTURE OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR SCIN-B','4H6I'),(236,'IDENTIFICATION OF CYS 255 IN HIF-1 AS A NOVEL SITE FOR DEVELOPMENT OF','4H6J'),(237,'W116I MUTANT OF OYE1','4H6K'),(238,'STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX','4H6O'),(239,'CRYSTAL STRUCTURE OF A PUTATIVE CHROMATE REDUCTASE FROM','4H6P'),(240,'STRUCTURE OF OXIDIZED DEINOCOCCUS RADIODURANS PROLINE DEHYDROGENASE','4H6Q'),(241,'STRUCTURE OF REDUCED DEINOCOCCUS RADIODURANS PROLINE DEHYDROGENASE','4H6R'),(242,'CRYSTAL STRUCTURE OF THROMBIN MUTANT E14EA/D14LA/E18A/S195A','4H6S'),(243,'CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT E14EA/D14LA/E18A/S195A','4H6T'),(244,'TUBULIN ACETYLTRANSFERASE MUTANT','4H6U'),(245,'STRUCTURE OF PATELLAMIDE MATURATION PROTEASE PATA','4H6V'),(246,'STRUCTURE OF PRENYLAGARAMIDE MATURATION PROTEASE PAGA','4H6W'),(247,'STRUCTURE OF PATELLAMIDE MATURATION PROTEASE PATG','4H6X'),(248,'CRYSTAL STRUCTURE OF THE DH-PH-PH DOMAIN OF FARP1','4H6Y'),(249,'TUBULIN ACETYLTRANSFERASE','4H6Z'),(250,'CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT','5BMF'),(251,'NITROXIDE SPIN LABELS IN PROTEIN GB1: E15 MUTANT','5BMG'),(252,'NITROXIDE SPIN LABELS IN PROTEIN GB1: T44 MUTANT, CRYSTAL FORM B','5BMH'),(253,'NITROXIDE SPIN LABELS IN PROTEIN GB1: T44 MUTANT, CRYSTAL FORM A','5BMI'),(254,'ROCK 1 BOUND TO A PYRIDINE THIAZOLE INHIBITOR','5BML'),(255,'SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC25B','5BMM'),(256,'CRYSTAL STRUCTURE OF APO FORM OF PHOSPHOGLUCOMUTASE FROM XANTHOMONAS','5BMN'),(257,'LNMX PROTEIN, A PUTATIVE GLCNAC-PI DE-N-ACETYLASE FROM STREPTOMYCES','5BMO'),(258,'CRYSTAL STRUCTURE OF PHOSPHOGLUCOMUTASE FROM XANTHOMONAS CITRI','5BMP'),(259,'CRYSTAL STRUCTURE OF L,D-TRANSPEPTIDASE (YKU) FROM STACKEBRANDTIA','5BMQ'),(260,'CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 4 IN COMPLEX WITH AN','5BMS'),(261,'CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN (PARMER_03598) FROM','5BMT'),(262,'THE CRYSTAL STRUCTURE OF THE GST-LIKE DOMAINS COMPLEX OF AIMP3-EPRS','5BMU'),(263,'CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-VINBLASTINE COMPLEX','5BMV'),(264,'CRYSTAL STRUCTURE OF T75V MUTANT OF TRIOSEPHOSPHATE ISOMERASE FROM','5BMW'),(265,'CRYSTAL STRUCTURE OF T75N MUTANT OF TRIOSEPHOSPHATE ISOMERASE FROM','5BMX'),(266,'CRYSTAL STRUCTURE OF HPIN1 WW DOMAIN (5-21) FUSED WITH MALTOSE-BINDING','5BMY'),(267,'CRYSTAL STRUCTURE OF PUTATIVE MARR FAMILY TRANSCRIPTIONAL REGULATOR','5BMZ'),(268,'STRUCTURE OF TRANSFERASE MUTANT-C23S,C199S','5H60'),(269,'STRUCTURE OF TRANSFERASE MUTANT-C23S,C199S','5H61'),(270,'STRUCTURE OF TRANSFERASE MUTANT-C23S,C199S','5H62'),(271,'STRUCTURE OF TRANSFERASE MUTANT-C23S,C199S','5H63'),(272,'CRYO-EM STRUCTURE OF MTORC1','5H64'),(273,'CRYSTAL STRUCTURE OF HUMAN POT1 AND TPP1','5H65'),(274,'CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS SMC HEAD DOMAIN COMPLEXED','5H66'),(275,'CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS SMC HEAD DOMAIN COMPLEXED','5H67'),(276,'CRYSTAL STRUCTURE OF AN ENGAGED DIMER OF THE GEOBACILLUS','5H68'),(277,'CRYSTAL STRUCTURE OF AN ASYMMETRIC DIMER OF THE GEOBACILLUS','5H69'),(278,'CRYSTAL STRUCTURE OF A THERMOSTABLE LIPASE FROM MARINE STREPTOMYCES','5H6B'),(279,'CRYSTAL STRUCTURE OF A THERMOSTABLE LIPASE FROM MARINE STREPTOMYCES','5H6G'),(280,'CRYSTAL STRUCTURE OF HYPERTHERMOPHILIC THERMOTOGA MARITIMA L-RIBULOSE','5H6H'),(281,'CRYSTAL STRUCTURE OF GBS CAMP FACTOR','5H6I'),(282,'DNA TARGETING ADP-RIBOSYLTRANSFERASE PIERISIN-1 IN COMPLEX WITH BETA-','5H6J'),(283,'DNA TARGETING ADP-RIBOSYLTRANSFERASE PIERISIN-1','5H6K'),(284,'DNA TARGETING ADP-RIBOSYLTRANSFERASE PIERISIN-1 IN COMPLEX WITH BETA-','5H6L'),(285,'DNA TARGETING ADP-RIBOSYLTRANSFERASE PIERISIN-1','5H6M'),(286,'DNA TARGETING ADP-RIBOSYLTRANSFERASE PIERISIN-1, AUTOINHIBITORY FORM','5H6N'),(287,'PORPHOBILINOGEN DEAMINASE FROM VIBRIO CHOLERAE','5H6O'),(288,'CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH PEPTIDE 11','5H6Q'),(289,'CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH PEPTIDE 13','5H6R'),(290,'CRYSTAL STRUCTURE OF HYDRAZIDASE S179A MUTANT COMPLEXED WITH A','5H6S'),(291,'CRYSTAL STRUCTURE OF HYDRAZIDASE FROM MICROBACTERIUM SP. STRAIN HM58-2','5H6T'),(292,'STRUCTURE OF ALGINATE-BINDING PROTEIN ALGQ2 IN COMPLEX WITH AN','5H6U'),(293,'STRUCTURE OF ZIKA VIRUS PROTEASE IN COMPLEX WITH A DIPEPTIDE INHIBITOR','5H6V'),(294,'STRUCTURE OF ACETYL-COENZYME A SYNTHASE ALPHA SUBUNIT C-TERMINAL','5H6W'),(295,'THE CRYSTAL STRUCTURE OF RPOS FRAGMENT INCLUDING A PARTIAL REGION 1.2','5H6X'),(296,'THE BPTF BROMODOMAIN RECOGNISING H4K12CR PEPTIDE','5H6Y'),(297,'CRYSTAL STRUCTURE OF SET7, A NOVEL HISTONE METHYLTRANSFERASE IN','5H6Z'),(298,'CRYO-EM STRUCTURE OF HUMAN CPSF-160-WDR33 COMPLEX AT 3.8 A RESOLUTION','6BM0'),(299,'POL II ELONGATION COMPLEX WITH AN ABASIC LESION AT I-1 POSITION','6BM2'),(300,'POL II ELONGATION COMPLEX WITH AN ABASIC LESION AT I-1 POSITION,','6BM4'),(301,'CRYSTAL STRUCTURE OF THE METH REACTIVATION DOMAIN BOUND TO ADOMET','6BM5'),(302,'CRYSTAL STRUCTURE OF THE METH REACTIVATION DOMAIN BOUND TO ADOHCY','6BM6'),(303,'CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI ADOMETDC/PROZYME HETERODIMER','6BM7'),(304,'CRYSTAL STRUCTURE OF GLYCOPROTEIN B FROM HERPES SIMPLEX VIRUS TYPE I','6BM8'),(305,'DIRECTED EVOLUTIONARY CHANGES IN MBL SUPER FAMILY - VIM-2 ROUND 10','6BM9'),(306,'THE CRYSTAL STRUCTURE OF INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE FROM','6BMA'),(307,'CRYSTAL STRUCTURE OF ARABIDOPSIS DEHYDROQUINATE DEHYDRATASE-SHIKIMATE','6BMB'),(308,'THE STRUCTURE OF A DIMERIC TYPE II DAH7PS ASSOCIATED WITH PYOCYANIN','6BMC'),(309,'RNA HAIRPIN CONTAINING GPPPG-OLIGO TO MIMIC INTERMEDIATE FORMED BY','6BMD'),(310,'CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII THB4','6BME'),(311,'VPS4P-VTA1P COMPLEX WITH PEPTIDE BINDING TO THE CENTRAL PORE OF VPS4P','6BMF'),(312,'STRUCTURE OF RECOMBINANT DWARF SPERM WHALE MYOGLOBIN (OXY)','6BMG'),(313,'CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN','6BMH'),(314,'CRYSTAL STRUCTURE OF GLTPH R397C IN COMPLEX WITH L-SERINE','6BMI'),(315,'CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN','6BMK'),(316,'STRUCTURE OF HUMAN DHHC20 PALMITOYLTRANSFERASE, IRREVERSIBLY INHIBITED','6BML'),(317,'STRUCTURE OF HUMAN DHHC20 PALMITOYLTRANSFERASE, SPACE GROUP P21','6BMM'),(318,'STRUCTURE OF HUMAN DHHC20 PALMITOYLTRANSFERASE, SPACE GROUP P63','6BMN'),(319,'CRYSTAL STRUCTURE OF ARABIDOPSIS DEHYDROQUINATE DEHYDRATASE-SHIKIMATE','6BMQ'),(320,'NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH','6BMR'),(321,'PALMITOYLTRANSFERASE STRUCTURE','6BMS'),(322,'CRYSTAL STRUCTURE OF A RECOMBINANT FORM OF HUMAN MYELOPEROXIDASE BOUND','6BMT'),(323,'NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH','6BMU'),(324,'NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH','6BMV'),(325,'NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH','6BMW'),(326,'NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH','6BMX'),(327,'NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH','6BMY'),(328,'INFLUENZA A M2 TRANSMEMBRANE DOMAIN BOUND TO A SPIROADAMANTANE','6BMZ'),(329,'PSEUDO-ATOMIC STRUCTURAL MODEL OF THE E3BP COMPONENT OF THE HUMAN','6H60'),(330,'CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 89 DEGREE TWIST AND','6H61'),(331,'QTRT1, THE CATALYTIC SUBUNIT OF MURINE TRNA-GUANINE TRANSGLYCOSYLASE','6H62'),(332,'SEMISYNTHETIC [FEFE]-HYDROGENASE CPI WITH ETHANEDITHIOLATE [2FE]','6H63'),(333,'CRYSTAL STRUCTURE OF THE CRD-SAT','6H64'),(334,'CRYSTAL STRUCTURE OF THE BRANCHED-CHAIN-AMINO-ACID AMINOTRANSFERASE','6H65'),(335,'CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 93 DEGREE TWIST AND','6H66'),(336,'YEAST RNA POLYMERASE I ELONGATION COMPLEX STALLED BY CYCLOBUTANE','6H67'),(337,'YEAST RNA POLYMERASE I ELONGATION COMPLEX STALLED BY CYCLOBUTANE','6H68'),(338,'CRYSTAL STRUCTURE OF UNC119 IN COMPLEX WITH LCK PEPTIDE','6H6A'),(339,'STRUCTURE OF ALPHA-SYNUCLEIN FIBRILS','6H6B'),(340,'CARBOMONOXY MURINE NEUROGLOBIN F106A MUTANT','6H6C'),(341,'CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY','6H6D'),(342,'CRYSTAL STRUCTURE OF TCDB2-TCCC3 WITHOUT HYPERVARIABLE C-TERMINAL','6H6G'),(343,'CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY','6H6H'),(344,'FERRIC MURINE NEUROGLOBIN GLY-LOOP MUTANT','6H6I'),(345,'CARBOMONOXY MURINE NEUROGLOBIN GLY-LOOP MUTANT','6H6J'),(346,'THE STRUCTURE OF THE FKR MUTANT OF THE ARCHAEAL TRANSLATION INITIATION','6H6K'),(347,'MURINE NOROVIRUS PROTRUDING DOMAIN (CW3 STRAIN) IN COMPLEX WITH THE','6H6L'),(348,'CR10 MURINE NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH THE CD300LF','6H6M'),(349,'UBIJ-SCP2 UBIQUINONE SYNTHESIS PROTEIN','6H6N'),(350,'UBIJ-SCP2 UBIQUINONE SYNTHESIS PROTEIN','6H6O'),(351,'UBIJ-SCP2 UBIQUINONE SYNTHESIS PROTEIN','6H6P'),(352,'FRAGMENT DERIVED XIAP INHIBITOR','6H6Q'),(353,'FRAGMENT DERIVED XIAP INHIBITOR','6H6R'),(354,'SAD PHASING ON NICKEL-SUBSTITUTED HUMAN CARBONIC ANHYDRASE II','6H6S'),(355,'BINARY CRYSTAL STRUCTURE OF POSITIVELY AND NEGATIVELY SUPERCHARGED','6H6T'),(356,'UNITARY CRYSTAL STRUCTURE OF THE POSITIVELY SUPERCHARGED VARIANT','6H6U'),(357,'STRUCTURE OF THE UBID-CLASS ENZYME HMFF FROM PELOTOMACULUM','6H6V'),(358,'MOLYBDENUM STORAGE PROTEIN- H156A','6H6W'),(359,'STRUCTURE OF AN EVOLVED DIMERIC FORM OF THE UBID-CLASS ENZYME HMFF','6H6X'),(360,'GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-7','6H6Y'),(361,'GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-62','6H6Z'),(362,'CRYSTAL STRUCTURE OF THE TICK-BORNE ENCEPHALITIS VIRUS NS3 HELICASE IN','7BM0'),(363,'NOTUM_VALSARTAN COMPLEX','7BM1'),(364,'CRYSTAL STRUCTURE OF THE DNA-BINDING PROTEIN REMA FROM GEOBACILLUS','7BM2'),(365,'NOTUM ROSMARINIC ACID COMPLEX','7BM3'),(366,'CRYSTAL STRUCTURE OF ALPHA CARBONIC ANHYDRASE FROM SCHISTOSOMA MANSONI','7BM4'),(367,'CRYSTAL STRUCTURE OF FAB1, THE FAB FRAGMENT OF THE ANTI-BAMA','7BM5'),(368,'STRUCTURE-FUNCTION ANALYSIS OF A NEW PL17 OLIGOALGINATE LYASE FROM THE','7BM6'),(369,'NOTUM FRAGMENT 5E','7BM7'),(370,'CRYSTAL STRUCTURE OF THE C-TERMINALLY TRUNCATED CHROMOSOME-','7BM8'),(371,'CRYSTAL STRUCTURE OF 14-3-3 SIGMA IN COMPLEX WITH CIP2APS904 PEPTIDE','7BM9'),(372,'AG REPETITION ATTACHED TO AN EXTENDED I-MOTIF CLIP AT 3\'-END','7BMA'),(373,'NOTUM PPOH COMPLEX','7BMB'),(374,'CRYSTAL STRUCTURE OF 14-3-3 SIGMA IN COMPLEX WITH CIP2APS904 PEPTIDE','7BMC'),(375,'NOTUM TDZD8 COMPLEX','7BMD'),(376,'CRYSTAL STRUCTURE OF A R18W MUTANT OF THE DNA-BINDING PROTEIN REMA','7BME'),(377,'INHIBITOR OF MDM2-P53 INTERACTION','7BMG'),(378,'CRYSTAL STRUCTURE OF A LIGHT-DRIVEN PROTON PUMP LR (MAC) FROM','7BMH'),(379,'ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (ASPH) OXYGENASE AND TPR DOMAINS','7BMI'),(380,'ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (ASPH) OXYGENASE AND TPR DOMAINS','7BMJ'),(381,'ATP-COMPETITIVE PARTIAL ANTAGONISTS-\'PAIR\'S-RHEOSTATICALLY MODULATE','7BMK'),(382,'CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN C (OSPC) FROM BORRELIA','7BML'),(383,'CRYSTAL STRUCTURE OF POLYPHOSPHATE KINASE 2 FROM DEINOCOCCUS','7BMM'),(384,'HEWL IN CESIUM CHLORIDE (0.25 M CSCL IN PROTEIN BUFFER)','7BMO'),(385,'HEWL IN CESIUM CHLORIDE (0.25 M CSCL IN PROTEIN BUFFER AND CRYO','7BMP'),(386,'HEWL IN CESIUM CHLORIDE (1.71 M CSCL IN CRYO PROTECTANT)','7BMQ'),(387,'HEWL IN CESIUM CHLORIDE (0.25 M CSCL IN PROTEIN BUFFER AND 1.71 M CSCL','7BMR'),(388,'HEWL IN CESIUM CHLORIDE (1.5 M CSCL IN CRYSTALLIZATION CONDITION AND','7BMS'),(389,'HEWL IN SODIUM CHLORIDE','7BMT'),(390,'P62PH IN CESIUM CHLORIDE (0.25 M CSCL IN PROTEIN BUFFER)','7BMU'),(391,'P62PH IN CESIUM CHLORIDE (0.25 M CSCL IN PROTEIN BUFFER AND CRYO','7BMV'),(392,'P62PH IN CESIUM CHLORIDE (0.75 M CSCL IN CRYO PROTECTANT)','7BMW'),(393,'P62PH IN CESIUM CHLORIDE (0.25 M CSCL IN PROTEIN BUFFER AND 0.75 M','7BMX'),(394,'P62PH IN CESIUM CHLORIDE (0.7 M CSCL IN CRYSTALLIZATION CONDITION AND','7BMY'),(395,'P62PH IN POTASSIUM CHLORIDE','7BMZ');
/*!40000 ALTER TABLE `proteins` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

